Clinical features and prognostic factors of adrenocortical carcinoma with hypercortisolism
10.3760/cma.j.cn311282-20230603-00250
- VernacularTitle:伴皮质醇增多症的肾上腺皮质癌临床特征及预后影响因素分析
- Author:
Ziwei ZHANG
1
;
Menglian LI
;
Chaoyang TIAN
;
Yangjie ZENG
;
Yijie WANG
;
Mengsi LIU
;
Ping LI
Author Information
1. 南京大学医学院附属鼓楼医院内分泌科，国家代谢性疾病临床医学研究中心分中心，南京 210008
- Keywords:
Adrenocortical carcinoma;
Hypercortisolism;
Prognostic factors
- From:
Chinese Journal of Endocrinology and Metabolism
2023;39(12):1010-1015
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To identify the clinical and pathological characteristics of adrenocortical carcinoma(ACC) with hypercortisolism and analyze the prognostic factors.Methods:Clinical data of ACC patients between January 2003 and December 2022 from Nanjing Drum Tower Hospital were collected retrospectively. Clinical and pathological characteristics were compared between ACC patients with hypercortisolism and nonfunctional ACCs. Kaplan-Meier method was used for survival analyses and Cox regression models were performed to analyze prognostic factors for ACC patients.Results:In 61 cases of ACC patients, the average age was (49.33±16.32) years. After a median follow-up of 77 months(95% CI 47.49-106.51 months), median overall survival and progression-free survival were 50 months(95% CI 20.44-79.56 months) and 29 months(95% CI 22.87-35.13 months), respectively. Among 36 patients with complete endocrinologic evaluations, 19(52.77%) were diagnosed with hypercortisolism. Compared with nonfunctional ACC, patients with hypercortisolism had more hypokalemia(42.11% vs 6.25%, P=0.022), capsular invasion(68.42% vs 25.00%, P=0.018), and distant metastases(73.68% vs 25.00%, P=0.007). Median overall survival and progression-free survival were significantly shorter than nonfunctional ACC(overall survival: 39 months vs 67 months, P=0.009; progression-free survival: 30 months vs 51 months, P=0.040) as well. Multivariate Cox regression analyses indicated that Ki67 index( HR=1.078, P=0.024) was an independent risk factor for overall survival. Hypercortisolism( HR=71.112, P=0.006), Ki67 index( HR=1.345, P=0.003), adjuvant therapy( HR=176.652, P=0.012), and operation( HR=0.020, P=0.003), were associated with disease progression. Conclusion:ACC accompanied by hypercortisolism is more prone to invasion and distant metastasis, resulting in shorter survival. Hypercortisolism is an independent prognostic factor for ACC patients.
